rethinkPeptides Search
Menu
Study breakdown

Type 1 and Type 2 Diabetes Show Opposite Hormone Responses to Low Blood Sugar

evidence
The takeaway

T1D patients showed exaggerated growth hormone response while T2D showed elevated ACTH/cortisol during hypoglycemia, revealing distinct peptide hormone counter-regulatory mechanisms between diabetes subtypes.

Opposite hormonal defenses

T1D mounts a growth hormone defense while T2D relies on cortisol — fundamentally different peptide hormone responses to the same metabolic threat

What the researchers found

T1D: elevated basal GH (p=0.002), exaggerated GH response to hypoglycemia (p=0.002). T2D: higher ACTH (p=0.024) and cortisol (p=0.043) during hypoglycemia, lower testosterone, higher estradiol vs T1D (p<0.001).

Why it matters

Understanding distinct counter-regulatory hormone responses could lead to subtype-specific diabetes management strategies to prevent dangerous hypoglycemia.

How the study worked

Hyperinsulinemic euglycemic-hypoglycemic clamps in drug-naive newly diagnosed T2DM, T1DM, and non-diabetic controls, with serial measurement of pituitary-adrenal hormones, GH, C-peptide, and sex steroids.

What this study cannot tell us

Newly diagnosed patients only. Small study. Cross-sectional — cannot determine if differences are cause or consequence. Drug-naive requirement limits generalizability.

How to read the evidence

Controlled clamp study in drug-naive patients — rigorous metabolic physiology methodology.

When this study was published

Published in 2025.

The bigger picture

Diabetes subtypes are biologically distinct at the neuroendocrine level, with different peptide hormone profiles that may require different management approaches.

Questions still open

  • Could GH suppression therapy improve glucose stability in T1D?
  • Does the cortisol excess in T2D respond to GLP-1 drug treatment?
  • Would sex steroid differences affect cardiovascular risk differently?

Common questions

Do type 1 and type 2 diabetes respond to low blood sugar differently?
Yes. T1D patients mount a strong growth hormone response while T2D patients rely more on cortisol/ACTH. These different peptide hormone defenses may explain why glucose control challenges differ between subtypes.
Why does this matter for treatment?
The exaggerated growth hormone in T1D may cause glucose rebounds after hypoglycemia, while elevated cortisol in T2D may worsen insulin resistance. Understanding these differences could lead to better-targeted treatments.

Read the original research

Distinct Pituitary-Adrenal Responses to Hypoglycemia in Type 1 and Type 2 Diabetes.

Endocrinology and metabolism (Seoul, Korea), 41(1), 162-173

Citation

Hu, Yun; Yan, Reng-Na; Cai, Ting-Ting; Zhu, Xiao-Wei; Ma, Jian-Hua; Ding, Bo. (2026). Distinct Pituitary-Adrenal Responses to Hypoglycemia in Type 1 and Type 2 Diabetes.. Endocrinology and metabolism (Seoul, Korea), 41(1), 162-173. https://doi.org/10.3803/EnM.2025.2479